Short answer
Indivior Pharmaceuticals, Inc. (INDV) filed an 8-K current report with the SEC on October 15, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved Indivior share issuance for the merger, clearing the Nasdaq Rule 5635 approval requirement.
Indivior Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders approved Indivior share issuance for the merger, clearing the Nasdaq Rule 5635 approval requirement
- 85,455,705 votes for versus 5,563,744 against, with 186,733 abstentions
- 91,206,182 shares represented, equal to 77.27% of 118,031,934 outstanding shares, establishing a quorum
- Merger execution can proceed past the shareholder approval milestone, subject to remaining closing conditions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Indivior Pharmaceuticals, Inc. 8-K filings
Get the next INDV 8-K as it lands
Follow INDV for push alerts, or ask the research agent what this filing means.